glp-1 triquetra GLP-Activate Investigation Triquetra Health, PX Therapeutics™, GLP-Pro™

Group III

ZR2021MH039, 8217021865), Clinical Science and Technology Innovation Program (grant no

Disclosures: Pojsakorn Danpanichkul: Nothing to Disclose, Kwanjit Duangsonk: Nothing to Disclose, Primrose Tothanarungroj: Nothing to Disclose, Thanida Auttapracha: Nothing to Disclose, Cheng Han Ng: Nothing to Disclose, Benedix Sim: Nothing to Disclose, Daniel Tung: Nothing to Disclose, Daniel Huang: Nothing to Disclose, Hirokazu Takahashi: Nothing to Disclose, Robert Wong: Theratechnologies: Grant/Research Support, Durect: Grant/Research Support, Gilead Sciences: Grant/Research Support, Exact Sciences: Grant/Research Support, Theratechnologies: Grant/Research Support, Durect Corporation: Grant/Research Support, Lorenzo Leggio: Nothing to Disclose, Ju Dong Yang: Nothing to Disclose, Vincent Chen: AstraZeneca: site PI on industry-sponsored trial, Ipsen: site co-I on industry-sponsored trial, Kowa: site co-I on industry-sponsored trial, Mazen Noureddin: ltimmune, BI, Cytodyn, 89BIO, GSK, Madrigal, Merck, Novo Nor: Terns,Takeda, Zydus., Allergan, Akero, BI, BMS, Gilead, Galectin, Zydus GSK: Terns, Corcept, Takeda, Madrigal, Novartis, Novo Nordisk, Rivus Pharma, Cytodyn, and ChronWell: Stock privately held company, Luis Antonio Diaz: Nothing to Disclose, Juan Pablo Arab: Nothing to Disclose, Suthat Liangpunsakul: DURECT: Consultant, Durect Corporation: Consultant, Surrozen: Consultant, Korro Bio: Consultant, Karn Wijarnpreecha: Nothing to Disclose 1435 VITAMIN D DEFICIENCY EXACERBATES ALCOHOL-ASSOCIATED LIVER DISEASE VIA GUT BARRIER DYSFUNCTION AND HEPATIC OVERLOAD OF ENDOTOXIN IN MICE KOSUKE KAJI 1 NORIHISA NISHIMURA 1 Shinya Sato 1 Tadashi Namisaki 1 Hitoshi Yoshiji 1 , 1 Nara Medical University Background: Endogenous lipopolysaccharide (LPS) that translocates via the disrupted intestinal barrier plays an essential role in the progression of alcohol-related liver disease (ALD)

Read our guide on how long semaglutide lasts in the fridge for additional storage details

Mental health status was measured at time of GLP-1 receptor agonist initiation and assessed again at 1216 weeks when the semi-structured interview took place